Independent information. England-wide.Public data. Clear sources.

NCT06588478

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Registered research study with 7 identifiable England locations. See source dates, location-specific recruitment and the original study record.

Study facts

Conditions recorded
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Lead sponsor
Loxo Oncology, Inc.
Study type
Interventional
Overall status
Recruiting · this can differ by location
Age range in the record
18 Years to Not specified
Sex eligibility field
All
Healthy volunteers accepted
No, according to the record
Phase
Phase2
Study record last updated
19 May 2026
Study team last verified status
2026-05

These fields are a starting point. Eligibility can include diagnosis, treatment history and other criteria shown only in the complete source record. A registry entry does not establish treatment effectiveness.

England study locations

A location is reproduced as named in the study record. A source map point can represent a town; it is not used here as a hospital entrance or to identify a care provider.

Location in the sourceLocal recruitment statusGeographic connection
Heartlands Hospital

Birmingham · B9 5SS

RecruitingCare in Birmingham

England postcode

Northwick Park Hospital

Harrow · HA1 3UJ

RecruitingCare in Brent

England postcode

St James's University Hospital

Leeds · LS9 7TF

RecruitingCare in Leeds

England postcode

Lincoln County Hospital

Lincoln · LN2 5QY

RecruitingCare in Lincoln

England postcode

Clatterbridge Cancer Centre - Liverpool

Liverpool · L7 8YA

RecruitingCare in Liverpool

England postcode

Hammersmith Hospital

London · W12 0HS

RecruitingCare in Hammersmith and Fulham

England postcode

Maidstone Hospital

Maidstone · ME16 9QQ

RecruitingCare in Maidstone

England postcode

Questions for the research team

  • Is this exact location currently enrolling participants, and do my circumstances meet the full criteria?
  • What visits, tests, possible risks and follow-up would participation involve?
  • Are travel costs or accessibility arrangements available?
  • How would participation affect my usual care, and what happens if I withdraw?

Source: ClinicalTrials.gov, a United States Government database. Contains OS data © Crown copyright and database right 2026. Contains National Statistics data © Crown copyright and database right 2024; ONS country boundaries (December 2024).

Source processed: 2026-09-10 09:00:04 UTC. Retrieved: 10 September 2026. ClinicalTrials.gov terms.

How we selected and connected these records

Selected registered studies with an overall status of Recruiting or Not yet recruiting and at least one England location established by postcode, recorded nation, or source coordinates within the ONS December 2024 boundary. Retained structured fields; omitted descriptions, eligibility text, contacts and non-England locations. Deduplicated identical locations. Linked local care areas only by exact postcode geography. Location points are used for nation filtering, not directions or facility matching.